In addition to being a key transcriptional regulator during embryogenesis and in adult stem cells, a role for ASCL1 has been demonstrated in a range of solid neuronal and neuroendocrine tumours such as glioblastoma, neuroblastoma, small cell lung cancer and prostate cancer [13–19]. Here, ASCL1 is linked to prostate carcinoma.